statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within...

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024

For the last three days, A.I.dvisor has detected that ARCT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Arcturus Therapeutics Holdings (ARCT, $33.09) Aroon Indicator entered a Downtrend on April 01, 2024.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Get Free Report) has been given a consensus rating of "Buy" by the seven research firms that are covering the stock, MarketBeat.com reports. Seven...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Rating of "Buy" from Brokerages

Arcturus Therapeutics Holdings (ARCT, $33.71) Aroon Indicator entered a Downtrend on March 28, 2024.

Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares

Arcturus Therapeutics Holdings (ARCT, $32.83) Aroon Indicator entered a Downtrend on March 27, 2024.

Arcturus Therapeutics Holdings (ARCT, $32.1) Aroon Indicator entered a Downtrend on March 26, 2024.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT  Get Free Report) COO Pad Chivukula sold 8,565 shares of Arcturus Therapeutics stock in a transaction on Tuesday, March 19th. The shares were...

Insider Selling: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells $299,860.65 in Stock

Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...

This is a signal that ARCT's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Arcturus Therapeutics Holdings (ARCT, $38.69) Stochastic Oscillator left the oversold zone on March 12, 2024

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Watchers	4,903
52-Wk Low	$17.52
52-Wk High	$43.81

Volume	274,832.00
52-Wk High	$43.81
52-Wk Low	$17.52

Period	Estimated	Reported	Surprise	Result
Q1'24	-$1.23	--	--	N/A
Q4'23	-$1.03	-$0.32	68.91%	BEAT
Q3'23	-$1.69	-$0.61	63.94%	BEAT
Q2'23	-$0.24	-$1.98	-709.15%	MISSED
Q1'23	$0.06	$1.87	3032.64%	BEAT

ARCT Arcturus Therapeutics Holdings Inc

About

Feed

News

Sentiment

Earnings

Fundamentals